Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › NC › Wilmington › NPI 1548216880
Hospital

New Hanover Regional Medical Center

New Hanover Regional Medical Center was paid $23.67M by Medicaid between Jan 2018 and Jan 2021, across 180 billing codes. Its largest line is 99284, emergency room visit (serious) — 35% of everything it billed.

33Billing provider infoNEW HANOVER REGIONAL MEDICAL CENTER
WILMINGTON, NC 28401
33aNPI1548216880assigned 05/26/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.67M
24GClaims564,028
24DCodes billed180
24AFirst – last monthJan 2018 – Jan 2021
Compared with peers

Next to other General Acute Care Hospital providers in North Carolina

Rank by total paid#22 of 92
Median peer was paid$11.47M
This provider vs. median2.1×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$500K$1.0M2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2018186,891$9.08M
2019199,828$8.62M
2020162,697$5.35M
202114,612$622K
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 35% 32,318 31,028 $8.28M
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 26% 44,807 43,318 $6.09M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 7.5% 4,555 4,356 $1.77M
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 3.2% 50,882 41,519 $766K
93303 Transthoracic echocardiography for congenital cardiac anomalies, follow-up or limited study 1.5% 1,202 1,178 $351K
99214 Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 1.5% 15,328 14,628 $348K
99213 Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity 1.4% 17,916 16,026 $335K
41899 Unlisted procedure, dentoalveolar structures 1.3% 535 529 $315K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete 1.3% 728 711 $296K
G0378 Hospital observation service, per hour 1.2% 5,357 4,468 $288K
59025 Fetal non-stress test 1.2% 3,387 3,060 $280K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report 1.0% 8,416 7,980 $238K
168 more codes
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 32,691 $217K
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 3,101 $214K
G0379 Direct admission of patient for hospital observation care <1% 4,293 $209K
80048 Basic metabolic panel (calcium, ionized) <1% 24,488 $165K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 6,486 $155K
93325 <1% 1,302 $148K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,349 $129K
71046 Radiologic examination, chest; 2 views <1% 1,956 $126K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 5,447 $120K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 5,446 $120K
93320 <1% 1,191 $114K
84443 Thyroid stimulating hormone (TSH) <1% 6,955 $114K
71045 Radiologic examination, chest; single view <1% 3,728 $112K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 3,388 $104K
J3490 Unclassified drugs <1% 87,845 $102K
81220 CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants <1% 409 $93K
87389 Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies <1% 3,839 $90K
80053 Comprehensive metabolic panel <1% 11,158 $76K
43239 Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple <1% 360 $68K
83036 Hemoglobin; glycosylated (A1C) <1% 7,291 $65K
J7030 Infusion, normal saline solution , 1000 cc <1% 6,120 $63K
36415 Collection of venous blood by venipuncture <1% 31,379 $60K
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 7,372 $57K
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 609 $57K
70553 Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences <1% 67 $50K
96375 Therapeutic injection; each additional sequential IV push <1% 1,265 $50K
96361 Intravenous infusion, hydration; each additional hour <1% 2,124 $49K
81025 <1% 6,891 $47K
88184 <1% 1,737 $44K
96413 Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance <1% 823 $43K
81001 <1% 12,404 $43K
95819 <1% 234 $40K
85027 <1% 6,686 $39K
95810 Polysomnography; sleep staging with 4 or more additional parameters <1% 86 $37K
84439 <1% 3,832 $37K
76801 <1% 791 $36K
94060 <1% 269 $34K
87631 <1% 526 $33K
94760 <1% 2,854 $33K
86850 <1% 2,738 $31K
88175 Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer <1% 1,293 $31K
80061 Lipid panel <1% 2,706 $30K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 610 $29K
87086 Culture, bacterial; quantitative colony count, urine <1% 3,595 $28K
76770 <1% 195 $27K
88185 <1% 1,737 $26K
97802 <1% 447 $25K
99215 Doctor's office visit, returning patient (complex) <1% 798 $23K
70450 Computed tomography, head or brain; without contrast material <1% 162 $23K
86762 <1% 1,525 $22K
86592 <1% 5,557 $22K
86787 <1% 1,698 $22K
80076 <1% 2,810 $22K
97803 <1% 437 $21K
99204 Doctor's office visit, new patient (more involved) <1% 810 $21K
86800 <1% 1,141 $20K
94010 <1% 560 $19K
87536 <1% 1,771 $19K
86376 <1% 1,141 $17K
83001 <1% 843 $17K
83021 <1% 861 $16K
83002 <1% 839 $16K
84403 <1% 588 $16K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 1,380 $16K
86255 <1% 1,176 $15K
83516 <1% 1,201 $15K
93225 <1% 90 $14K
87340 <1% 1,537 $14K
82670 <1% 539 $14K
80306 <1% 911 $14K
87081 <1% 2,209 $13K
83655 <1% 1,074 $13K
83690 <1% 2,063 $12K
82784 <1% 1,177 $12K
81243 <1% 406 $10K
87798 Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism <1% 331 $9K
90472 Immunization administration, each additional vaccine (list separately) <1% 924 $9K
82533 <1% 435 $8K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 300 $8K
11042 Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm <1% 264 $7K
86703 <1% 551 $7K
82950 <1% 1,554 $7K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity <1% 450 $7K
87503 <1% 703 $7K
81003 <1% 2,753 $7K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 509 $7K
90715 <1% 1,406 $6K
69436 Tympanostomy (requiring insertion of ventilating tube), general anesthesia <1% 26 $5K
86803 <1% 366 $5K
J1439 Injection, ferric carboxymaltose, 1 mg <1% 42 $5K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 118 $5K
J2704 Injection, propofol, 10 mg <1% 1,244 $5K
85660 <1% 861 $5K
99203 Doctor's office visit, new patient (routine) <1% 201 $5K
83520 <1% 349 $5K
84305 <1% 328 $5K
82657 <1% 231 $5K
90686 <1% 3,813 $4K
J1756 Injection, iron sucrose, 1 mg <1% 24 $4K
J7120 Ringers lactate infusion, up to 1000 cc <1% 296 $4K
83525 <1% 275 $3K
87633 Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets <1% 12 $3K
71260 Computed tomography, thorax, diagnostic; with contrast material <1% 12 $3K
83540 <1% 478 $3K
94761 <1% 132 $3K
84484 <1% 433 $3K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction <1% 73 $3K
82728 <1% 178 $3K
G0108 Diabetes outpatient self-management training services, individual, per 30 minutes <1% 58 $3K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 141 $2K
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 1,560 $2K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 17 $2K
84445 <1% 36 $2K
86900 <1% 775 $2K
86901 <1% 775 $2K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 90 $2K
88342 <1% 42 $2K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 40 $2K
77336 <1% 29 $2K
76830 Ultrasound, transvaginal <1% 16 $2K
86003 <1% 13 $2K
85652 <1% 572 $2K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 29 $2K
86140 <1% 286 $1K
C9803 Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source <1% 74 $1K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 25 $1K
83735 <1% 206 $1K
99205 Prolong outpt/office vis <1% 32 $1K
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 922 $1K
85049 <1% 209 $946.98
95012 <1% 54 $705.44
85045 <1% 176 $702.85
85018 <1% 298 $689.15
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 454 $684.10
A9585 Injection, gadobutrol, 0.1 ml <1% 66 $682.35
85014 <1% 275 $636.05
84156 <1% 162 $617.90
82570 <1% 141 $613.34
J2270 Injection, morphine sulfate, up to 10 mg <1% 215 $569.72
83550 <1% 57 $504.18
84702 <1% 51 $468.70
J1170 Injection, hydromorphone, up to 4 mg <1% 103 $464.88
82565 <1% 58 $418.26
82043 <1% 87 $415.29
76817 Ultrasound, pregnant uterus, real time with image documentation, transvaginal <1% 26 $409.41
87486 <1% 12 $385.08
87581 <1% 12 $385.08
J3010 Injection, fentanyl citrate, 0.1 mg <1% 243 $304.43
83615 <1% 177 $270.46
90670 <1% 148 $215.71
84480 <1% 12 $212.04
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 183 $170.11
82248 <1% 45 $166.00
81050 <1% 25 $95.72
83880 <1% 12 $88.84
90474 <1% 15 $83.58
82962 <1% 12 $17.52
J1642 Injection, heparin sodium, (heparin lock flush), per 10 units <1% 340 $17.40
84550 <1% 181 $13.16
G0008 Administration of influenza virus vaccine <1% 152 $6.50
84450 0% 59 $0.00
81401 0% 60 $0.00
90681 0% 27 $0.00
82642 0% 315 $0.00
Q0111 Wet mounts, including preparations of vaginal, cervical or skin specimens 0% 182 $0.00
90647 0% 63 $0.00
90723 0% 41 $0.00
J7050 Infusion, normal saline solution, 250 cc 0% 22 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialOLLIE, EDWIN (CFO)